If you're a growth investor on the lookout for new options, then read on!
Listed below are two ASX growth that could be worth considering . Here's why analysts are tipping them as buys:
Aristocrat Leisure Limited (ASX: ALL)
The first ASX growth share to consider buying is Aristocrat Leisure. It is one of the world's leading gaming technology companies with a world class portfolio of poker machines and mobile games. The latter business, known as Pixel United, is home to popular mobile games such as Cashman Casino, Gummy Drop, EverMerge, Mech Arena, and RAID.
Aristocrat also recently expanded into the real money gaming market with a deal with MGM. This has the potential to be a very lucrative business in the future and is partly why Goldman Sachs is positive on the company. It commented:
Real Money Gaming opportunity was discussed to grow to penetrate at least 70% of the regulated jurisdictions in north America in the medium term. ALL will be targeting to take a significant share of the US iGaming market in the medium term with ambitions to be a leading global online RMG platform in the long term.
Goldman has a buy rating and $42.80 price target on its shares.
ResMed Inc. (ASX: RMD)
Another ASX growth share that has been tipped as a buy is ResMed. It is a medical device company with a focus on sleep treatment solutions.
Morgans rates the company highly due to its strong position in the sleep treatment market and its huge potential in the out of hospital care market. The broker commented:
Nothing changes our medium/longer term view that the company remains well-placed as it builds a unique, patient-centric, connected-care digital platform that addresses the main pinch points across the healthcare value chain.
Morgans has an add rating and $37.24 price target on its shares.
